MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans

Early Phase 1
Completed
Conditions
Alcohol Consumption
Tobacco Use
Interventions
First Posted Date
2008-02-15
Last Posted Date
2014-07-08
Lead Sponsor
Yale University
Target Recruit Count
18
Registration Number
NCT00616746
Locations
🇺🇸

VA Connecticut Healthcare System, West Haven Campus, West Haven, Connecticut, United States

Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation

Early Phase 1
Completed
Conditions
Stem Cell Transplantation
Interventions
First Posted Date
2008-02-11
Last Posted Date
2016-11-30
Lead Sponsor
Yale University
Target Recruit Count
26
Registration Number
NCT00612274
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

N-acetylcysteine and NMDA Antagonist Interactions

Phase 1
Completed
Conditions
Cognitive Dysfunction
Interventions
First Posted Date
2008-02-11
Last Posted Date
2015-05-08
Lead Sponsor
Yale University
Target Recruit Count
16
Registration Number
NCT00611897
Locations
🇺🇸

VHA Connecticut, West Haven, Connecticut, United States

GABA Mechanisms Underlying the Vulnerability to Alcohol Dependence

Not Applicable
Completed
Conditions
Alcoholism
Interventions
Drug: Placebo
First Posted Date
2008-02-11
Last Posted Date
2017-03-17
Lead Sponsor
Yale University
Target Recruit Count
73
Registration Number
NCT00611767
Locations
🇺🇸

VA Connecticut Healthcare System, West Haven, Connecticut, United States

GABA-glutamate Interactions and Psychosis

Phase 1
Completed
Conditions
Cognitive Dysfunction
Interventions
First Posted Date
2008-02-11
Last Posted Date
2022-07-22
Lead Sponsor
Yale University
Target Recruit Count
23
Registration Number
NCT00611572
Locations
🇺🇸

VHA Connecticut, West Haven, Connecticut, United States

The Effect of Plasma Osmolality on Brain Glutamate

Phase 1
Completed
Conditions
Schizophrenia
Interventions
Drug: furosemide, Na supplements
First Posted Date
2008-02-11
Last Posted Date
2016-02-09
Lead Sponsor
Yale University
Target Recruit Count
30
Registration Number
NCT00611741
Locations
🇺🇸

34 Park Street, CMHC, New Haven, Connecticut, United States

Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma

Not Applicable
Completed
Conditions
Breast Neoplasms
Interventions
Radiation: Mammosite brachytherapy radiation
First Posted Date
2008-02-11
Last Posted Date
2017-05-16
Lead Sponsor
Yale University
Target Recruit Count
28
Registration Number
NCT00611624
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

Effects of Atomoxetine Treatment in Humans

Phase 1
Completed
Conditions
Stress
Interventions
Drug: Placebo
First Posted Date
2008-02-11
Last Posted Date
2012-07-25
Lead Sponsor
Yale University
Target Recruit Count
10
Registration Number
NCT00611936

Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism

Not Applicable
Completed
Conditions
Alcoholism
Interventions
First Posted Date
2008-02-11
Last Posted Date
2021-10-26
Lead Sponsor
Yale University
Target Recruit Count
180
Registration Number
NCT00612352
Locations
🇺🇸

VA Connecticut Healthcare System, West Haven, Connecticut, United States

Galantamine Effects on Cognitive Function in Abstinent Cocaine Users

Not Applicable
Completed
Conditions
Cocaine Abuse
Interventions
Drug: placebo
First Posted Date
2008-02-05
Last Posted Date
2021-03-15
Lead Sponsor
Yale University
Target Recruit Count
34
Registration Number
NCT00606801
Locations
🇺🇸

Veterans Affairs Hospital, West Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath